New Pancreatic Cancer Drug Offers Hope for Patients Facing Deadly Disease
Pancreatic cancer drug daraxonrasib nearly doubled survival times in a major trial, offering new hope for patients with advanced disease.
News That Never Sleeps
Pancreatic cancer drug daraxonrasib nearly doubled survival times in a major trial, offering new hope for patients with advanced disease.